Accelerated vs regular approval pathways: Differences in study characteristics in the approval of lung cancer treatments by the FDA from 2006 to 2018

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorRIBEIRO, Tatiane
dc.contributor.authorBUSS, Lewis
dc.contributor.authorALI, Sanni
dc.contributor.authorNOBRE, Moacyr
dc.date.accessioned2021-01-25T19:35:02Z
dc.date.available2021-01-25T19:35:02Z
dc.date.issued2020
dc.description.indexMEDLINEeng
dc.identifier.citationPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, v.29, suppl.3, Special Issue, p.641-642, 2020
dc.identifier.eissn1099-1557
dc.identifier.issn1053-8569
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/38972
dc.language.isoeng
dc.publisherWILEYeng
dc.relation.ispartofPharmacoepidemiology and Drug Safety
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright WILEYeng
dc.subject.wosPublic, Environmental & Occupational Healtheng
dc.subject.wosPharmacology & Pharmacyeng
dc.titleAccelerated vs regular approval pathways: Differences in study characteristics in the approval of lung cancer treatments by the FDA from 2006 to 2018eng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryisogb
hcfmusp.author.externalALI, Sanni:London Sch Hyg & Trop Med, London, England
hcfmusp.contributor.author-fmusphcTATIANE CRISTINA RIBEIRO
hcfmusp.contributor.author-fmusphcLEWIS FLETCHER BUSS
hcfmusp.contributor.author-fmusphcMOACYR ROBERTO CUCE NOBRE
hcfmusp.description.beginpage641
hcfmusp.description.endpage642
hcfmusp.description.issuesuppl 3
hcfmusp.description.issueSpecial Issue
hcfmusp.description.volume29
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000577640502151
hcfmusp.publisher.cityHOBOKENeng
hcfmusp.publisher.countryUSAeng
relation.isAuthorOfPublication1a7bb61f-71aa-4e2c-86c2-9584a6ec9958
relation.isAuthorOfPublicationea41d7d2-230f-4b82-9923-48c2d66422a4
relation.isAuthorOfPublicationd49096ec-58f7-4f3c-a727-9e80ce69bf60
relation.isAuthorOfPublication.latestForDiscovery1a7bb61f-71aa-4e2c-86c2-9584a6ec9958
Arquivos
Coleções
Comunicações em Eventos - HC/InCor
Comunicações em Eventos - LIM/23
Comunicações em Eventos - LIM/38